Literature DB >> 17272398

Identification of the glomerular podocyte as a target for growth hormone action.

Gaddameedi R Reddy1, Mary J Pushpanathan, Richard F Ransom, Lawrence B Holzman, Frank C Brosius, Maria Diakonova, Peter Mathieson, Moin A Saleem, Edward O List, John J Kopchick, Stuart J Frank, Ram K Menon.   

Abstract

GH excess in both the human and transgenic animal models is characterized by significant changes in blood pressure and renal function. The GH/GH receptor (GHR) axis is also implicated in the development of diabetic nephropathy. However, it is not clear whether GH's actions on renal function are due to indirect actions mediated via changes in blood pressure and vascular tone or due to direct action of GH on the kidney. We hypothesized that functional GHRs are expressed on the glomerular podocyte enabling direct actions of GH on glomerular function. Real-time PCR, immunohistochemistry, and Western blot analysis of murine podocyte cells (MPC-5) and kidney glomeruli demonstrated expression of GHR mRNA and protein. Exposure of both murine and human podocytes to GH (50-500 ng/ml) resulted in an increase in abundance of phosphorylated signal transducer and activator of transcription-5, Janus kinase-2, and ERK1/2 proteins. Exposure of podocytes to GH also caused changes in the intracellular distribution of the Janus kinase-2 adapter protein Src homology 2-Bbeta, stimulation of focal adhesion kinase, increase in reactive oxygen species, and GH-dependent changes in the actin cytoskeleton. We conclude that glomerular podocytes express functional GHRs and that GH increases levels of reactive oxygen species and induces reorganization of the actin cytoskeleton in these cells. These results provide a novel mechanistic link between GH's actions and glomerular dysfunction in disorders such as acromegaly and diabetic glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17272398     DOI: 10.1210/en.2006-1285

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

Review 1.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

2.  Growth hormone (GH)-dependent expression of a natural antisense transcript induces zinc finger E-box-binding homeobox 2 (ZEB2) in the glomerular podocyte: a novel action of gh with implications for the pathogenesis of diabetic nephropathy.

Authors:  P Anil Kumar; Kateryna Kotlyarevska; Prapai Dejkhmaron; Gaddameedi R Reddy; Chunxia Lu; Mahaveer S Bhojani; Ram K Menon
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

3.  Aryl hydrocarbon receptor-dependence of dioxin's effects on constitutive mouse hepatic cytochromes P450 and growth hormone signaling components.

Authors:  Chunja Lee; David S Riddick
Journal:  Can J Physiol Pharmacol       Date:  2012-09-14       Impact factor: 2.273

4.  Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial.

Authors:  Otto Mehls; Anders Lindberg; Dieter Haffner; Franz Schaefer; Elke Wühl
Journal:  Pediatr Nephrol       Date:  2015-07-22       Impact factor: 3.714

5.  Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly.

Authors:  Peter Kamenicky; Say Viengchareun; Anne Blanchard; Geri Meduri; Philippe Zizzari; Martine Imbert-Teboul; Alain Doucet; Philippe Chanson; Marc Lombès
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

6.  Lack of an association between GHR exon 3 polymorphism and diabetic nephropathy in the Genetics of Kidneys in Diabetes (GoKinD) population.

Authors:  H F Gu; S Efendic; K Brismar
Journal:  Diabetologia       Date:  2008-09-05       Impact factor: 10.122

7.  Increased renal Akt/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation.

Authors:  Daniel Landau; Renanah Eshet; Ariel Troib; Yotam Gurman; Yu Chen; Ralph Rabkin; Yael Segev
Journal:  Endocrine       Date:  2009-04-23       Impact factor: 3.633

8.  Elevated systolic blood pressure in male GH transgenic mice is age dependent.

Authors:  Adam Jara; Chance M Benner; Don Sim; Xingbo Liu; Edward O List; Lara A Householder; Darlene E Berryman; John J Kopchick
Journal:  Endocrinology       Date:  2013-01-01       Impact factor: 4.736

9.  Adapter protein SH2B1beta cross-links actin filaments and regulates actin cytoskeleton.

Authors:  Leah Rider; Jing Tao; Stacy Snyder; Brittany Brinley; Jiayun Lu; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2009-04-02

10.  Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity.

Authors:  Xiangdong Wang; Jing Jiang; Jason Warram; Gerhard Baumann; Yujun Gan; Ram K Menon; Lee A Denson; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2008-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.